Development
GE HealthCare Technologies Inc.
GEHC
$71.62
$0.070.10%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 19.55B | 19.28B | 19.04B | 18.71B | 18.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.55B | 19.28B | 19.04B | 18.71B | 18.34B |
| Cost of Revenue | 11.63B | 11.59B | 11.50B | 11.31B | 11.16B |
| Gross Profit | 7.92B | 7.70B | 7.54B | 7.39B | 7.18B |
| SG&A Expenses | 3.81B | 3.70B | 3.73B | 3.66B | 3.62B |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.65B | 16.45B | 16.33B | 16.03B | 15.81B |
| Operating Income | 2.90B | 2.84B | 2.71B | 2.67B | 2.53B |
| Income Before Tax | 2.36B | 2.47B | 2.46B | 2.53B | 2.51B |
| Income Tax Expenses | 743.00M | 701.00M | 580.00M | 596.00M | 564.00M |
| Earnings from Continuing Operations | 1.62K | 1.77K | 1.88K | 1.93K | 1.95K |
| Earnings from Discontinued Operations | -4.00M | 2.00M | 6.00M | 18.00M | 18.00M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -46.00M | -52.00M | -51.00M | -49.00M | -51.00M |
| Net Income | 1.57B | 1.72B | 1.83B | 1.90B | 1.92B |
| EBIT | 2.90B | 2.84B | 2.71B | 2.67B | 2.53B |
| EBITDA | 3.51B | 3.46B | 3.34B | 3.31B | 3.17B |
| EPS Basic | 3.04 | 3.38 | 3.63 | 3.78 | 4.22 |
| Normalized Basic EPS | 3.14 | 3.30 | 3.27 | 3.37 | 3.35 |
| EPS Diluted | 3.03 | 3.37 | 3.62 | 3.77 | 4.21 |
| Normalized Diluted EPS | 3.12 | 3.29 | 3.26 | 3.36 | 3.35 |
| Average Basic Shares Outstanding | 1.82B | 1.82B | 1.82B | 1.82B | 1.82B |
| Average Diluted Shares Outstanding | 1.83B | 1.83B | 1.82B | 1.82B | 1.82B |
| Dividend Per Share | 0.12 | 0.09 | 0.06 | 0.03 | -- |
| Payout Ratio | 1.72% | 0.81% | 0.76% | -- | -- |